🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 13 Aug 2026 · ClinicalTrials.gov

Clinical Trials in China

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

97
Recruiting now
150
Active studies
Starting soon Phase 3
A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Lepu Biopharma Co., Ltd. · started 2027-01
📍 Shanghai
NCT07138846 on ClinicalTrials.gov ↗
By invitation
Effects of Remimazolam on Postoperative Myocardial Injury
Myocardial Injury
Affiliated Hospital of Jiaxing University · started 2026-08-01
📍 Jiaxing
NCT07725185 on ClinicalTrials.gov ↗
Starting soon Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis
China National Center for Cardiovascular Diseases · started 2026-08-01
📍 Beijing
NCT07762755 on ClinicalTrials.gov ↗
Starting soon Phase 3
A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease
Thyroid Eye Disease
Beijing Kanghong Biological Medicine Co., Ltd. · started 2026-08
📍 Shanghai
NCT07720648 on ClinicalTrials.gov ↗
Starting soon
Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression
PBC
Beijing Municipal Administration of Hospitals · started 2026-08
📍 Beijing
NCT07733882 on ClinicalTrials.gov ↗
Starting soon Phase 1
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd · started 2026-07-31
📍 Beijing
NCT07472790 on ClinicalTrials.gov ↗
Recruiting
Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
Aortic Regurgitation Disease
Shanghai Zhongshan Hospital · started 2026-07-18
📍 Shanghai
NCT07677410 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Psoriatic Arthritis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · started 2026-07-16
📍 Bozhou · Beijing · Chongqing · Dongguan · Guangzhou · Jiangmen
NCT07406035 on ClinicalTrials.gov ↗
Starting soon
Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery
Prostate Cancer
Xiangya Hospital of Central South University · started 2026-07
📍 Changsha
NCT07690462 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer
Colorectal Cancer (CRC)
Fudan University · started 2026-06-30
📍 Shanghai
NCT07683403 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Weight Management
AstraZeneca · started 2026-06-29
📍 Binzhou · Chengdu · Deyang · Ganzhou · Guangzhou · Haikou
NCT07667803 on ClinicalTrials.gov ↗
Recruiting Phase 1
Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients
pMMR/MSS Advanced Colorectal Cancer
West China Hospital · started 2026-06-11
📍 Chengdu
NCT07510308 on ClinicalTrials.gov ↗
Recruiting Phase 3
Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital · started 2026-05-22
📍 Tianjin
NCT07632118 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD · started 2026-05-12
📍 Nanjing
NCT07592585 on ClinicalTrials.gov ↗
Starting soon
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
Pulmonary Nodule, Suspected Lung Cancer, Preoperative Decision-Making
Sichuan Cancer Hospital and Research Institute · started 2026-05
📍 Chengdu
NCT07590596 on ClinicalTrials.gov ↗
Active Phase 2
Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.
Biliary Tract Cancers (BTC)
Tianjin Medical University Cancer Institute and Hospital · started 2026-04-24
📍 Tianjin
NCT07654530 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd. · started 2026-04-16
📍 Zhengzhou · Suzhou · Xi’an · Hangzhou
NCT07454187 on ClinicalTrials.gov ↗
Recruiting
AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Beijing Tsinghua Chang Gung Hospital · started 2026-04-13
📍 Beijing
NCT07538882 on ClinicalTrials.gov ↗
Recruiting
Effect of VR-MBCT in Chronic Nonspecific Low Back Pain
Chronic Non-specific Low Back Pain
The First Affiliated Hospital of Soochow University · started 2026-04-01
📍 Suzhou
NCT07589790 on ClinicalTrials.gov ↗
Recruiting
NK Cell Therapy for Malignant Solid Brain Tumors
Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM), Brain Metastasis
Peking University Third Hospital · started 2026-04
📍 Beijing · Qinhuangdao · Zhengzhou
NCT07552233 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Dihydroartemisinin for MAFLD
MAFLD
The First Affiliated Hospital with Nanjing Medical University · started 2026-03-30
📍 Nanjing
NCT07679542 on ClinicalTrials.gov ↗
Recruiting
A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca · started 2026-03-19
📍 Changchun · Changsha · Chengdu · Guangzhou · Haikou · Kunming
NCT07446738 on ClinicalTrials.gov ↗
Starting soon Phase 2
Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients
NSCLC Stage II
Shanghai Pulmonary Hospital, Shanghai, China · started 2026-03
📍 Shanghai
NCT07493980 on ClinicalTrials.gov ↗
Starting soon Phase 2/Phase 3
6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors
Thymoma and Thymic Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · started 2026-03
📍 Shanghai
NCT07463313 on ClinicalTrials.gov ↗
Recruiting Phase 1
To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · started 2026-02-26
📍 Guangzhou · Zhengzhou · Chengdu · Luzhou · Hangzhou
NCT07338838 on ClinicalTrials.gov ↗
Recruiting
Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury
Sepsis, Acute Kidney Injury Due to Sepsis, Gastrointestinal Microbiome, Sepsis-Associated Liver Injury
First Affiliated Hospital of Zhejiang University · started 2026-02-15
📍 Hangzhou
NCT07735182 on ClinicalTrials.gov ↗
Recruiting
Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer
Locally Advanced Rectal Cancer (LARC)
Beijing Friendship Hospital · started 2026-02-15
📍 Beijing
NCT07393048 on ClinicalTrials.gov ↗
Starting soon
Evaluation of the Efficacy of Red Light in Adult Patients With High and Extreme Myopia
Myopia
Beijing Tongren Hospital · started 2026-02-12
📍 Beijing
NCT07412678 on ClinicalTrials.gov ↗
Recruiting Phase 2
PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.
Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)
The First Affiliated Hospital with Nanjing Medical University · started 2026-02-07
📍 Nanjing
NCT07410520 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Janssen Research & Development, LLC · started 2026-02-04
📍 Beijing · Guangzhou · Hangzhou · Nanjing · Nanning · Shanghai
NCT07258511 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC · started 2026-01-29
📍 Beijing · Guangzhou · Jiangmen · Nanchang · Shanghai · Chengdu
NCT07227597 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
Health, Subjective
Jiangsu Simcere Pharmaceutical Co., Ltd. · started 2026-01-12
📍 Jinan
NCT07345364 on ClinicalTrials.gov ↗
Recruiting
Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
Robotic Surgical Procedures, Airway Extubation, Operating Rooms, Anesthesia Recovery Period
Peking University First Hospital · started 2026-01-12
📍 Beijing
NCT07332806 on ClinicalTrials.gov ↗
Starting soon Phase 3
Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma by AJCC V9 Stage
Fujian Cancer Hospital · started 2026-01-01
📍 Fuzhou
NCT07268690 on ClinicalTrials.gov ↗
Starting soon
Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
Stellate Ganglion Block, Prolonged Disorders of Consciousness, Sleep
Beijing Tiantan Hospital · started 2026-01-01
📍 Beijing
NCT07274683 on ClinicalTrials.gov ↗
Starting soon Phase 1
KN5501 Cell Injection for Refractory SLE(CLEAR)
Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD · started 2026-01
📍 Bengbu · Beijing · Luoyang · Wuhan · Nanjing · Shanghai
NCT07358988 on ClinicalTrials.gov ↗
Starting soon Phase 2
A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
Rhabdomyosarcoma
Fudan University · started 2026-01
📍 Shanghai
NCT07355855 on ClinicalTrials.gov ↗
Recruiting Phase 1
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
Advanced Cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · started 2025-12-16
📍 Guangzhou · Zhengzhou · Changsha · Nanjing · Nanchang · Dalian
NCT07260708 on ClinicalTrials.gov ↗
Recruiting
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
Herpes Zoster, Mirogabalin, Pain
Beijing Tiantan Hospital · started 2025-12-15
📍 Beijing
NCT07307170 on ClinicalTrials.gov ↗
Recruiting
Feasibility Study of Diaphragm Synchronized Pacing (DSP) Via the Left Inferior Phrenic Vein (LIPV) Approach
Heart Failure
RenJi Hospital · started 2025-11-28
📍 Shanghai
NCT07392749 on ClinicalTrials.gov ↗
Recruiting
Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
Lung Cancer
Ruijin Hospital · started 2025-11-21
📍 Shanghai
NCT07232433 on ClinicalTrials.gov ↗
Recruiting Phase 2
AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)
Colorectal Cancer Liver Metastases (CRLM)
Fudan University · started 2025-11-04
📍 Shanghai
NCT07544784 on ClinicalTrials.gov ↗
Recruiting Phase 2
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital · started 2025-11-03
📍 Tianjin
NCT07162506 on ClinicalTrials.gov ↗
Starting soon Phase 3
Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase, Thrombolysis
The First Affiliated Hospital of University of Science and Technology of China · started 2025-11-01
📍 Hefei
NCT07168278 on ClinicalTrials.gov ↗
Starting soon
Effectiveness of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction in Pediatric Tethered Cord Syndrome Post-Surgery
Postoperative Neurogenic Lower Urinary Tract Dysfunction Secondary to Tethered Cord Syndrome
Shanghai Institute of Acupuncture, Moxibustion and Meridian · started 2025-11-01
📍 Shanghai
NCT07062133 on ClinicalTrials.gov ↗
Recruiting
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
Hip Fractures (ICD-10 72.01-72.2), Osteoarthritis, Knee and Hip, Femoral Neck Fractures
Shanghai Geriatric Medical Center · started 2025-10-28
📍 Shanghai
NCT07301242 on ClinicalTrials.gov ↗
Recruiting Phase 2
Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis
Leptomeningeal Metastasis of HER2-positive Breast Cancer
The First Affiliated Hospital with Nanjing Medical University · started 2025-10-27
📍 Nanjing
NCT07263425 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Breast Cancer
Genentech, Inc. · started 2025-10-07
📍 Jinan · Shanghai · Tianjin
NCT07100106 on ClinicalTrials.gov ↗
Starting soon
Organ Dysfunction Changes in Acute Necrotizing Pancreatitis Patients With Sepsis Following Open Necrosectomy
Necrotizing Pancreatitis
West China Hospital · started 2025-10-05
📍 Chengdu
NCT07201246 on ClinicalTrials.gov ↗
Active
Automated Reports Generation of Cardiovascular Magnetic Resonance Imaging
HCM - Hypertrophic Cardiomyopathy
Chinese Academy of Medical Sciences, Fuwai Hospital · started 2025-10-01
📍 Beijing
NCT07340762 on ClinicalTrials.gov ↗
Recruiting
A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis
Palmoplantar Pustulosis (PPP)
Xijing Hospital · started 2025-10-01
📍 Xi'an
NCT07270003 on ClinicalTrials.gov ↗
Starting soon
Advancing Assessment for Disorders of Consciousness
Disorders of Consciousness
Xuanwu Hospital, Beijing · started 2025-09-25
📍 Beijing
NCT07180589 on ClinicalTrials.gov ↗
Recruiting Phase 2
Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer
Metastatic Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University · started 2025-09-01
📍 Nanjing
NCT07718490 on ClinicalTrials.gov ↗
Recruiting
Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation
Hearing Loss, Hearing Loss, Sensorineural, Deafness, Cochlear Implantation
Eye & ENT Hospital of Fudan University · started 2025-08-22
📍 Shanghai
NCT07380269 on ClinicalTrials.gov ↗
Recruiting Phase 2
Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer
Pancreatic Cancer Non-resectable
Shandong Cancer Hospital and Institute · started 2025-08-14
📍 Jinan
NCT07600268 on ClinicalTrials.gov ↗
Recruiting Phase 1
Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients
Bladder (Urothelial, Transitional Cell) Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · started 2025-08-01
📍 Guangzhou
NCT07119996 on ClinicalTrials.gov ↗
By invitation
Scalp Acupuncture Treatment for Chronic Tic Disorders in Children
Tic Disorder
Children's Hospital of Fudan University · started 2025-08-01
📍 Shanghai
NCT06924918 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
Colorectal Carcinoma
Fudan University · started 2025-08-01
📍 Anyang · Shanghai
NCT07025850 on ClinicalTrials.gov ↗
Starting soon
Efficacy and Safety of Contrast EUS-Guided Tissue Glue/Coil Devascularization vs. BRTO for Preventing Recurrent Gastric Variceal Bleeding
Gastric Varices Bleeding
West China Hospital · started 2025-07-30
📍 Chengdu
NCT07049146 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
Immunotherapy, Gastric Cancer (GC), Radiotherapy, Neoadjuvant Therapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · started 2025-07-23
📍 Chongqing
NCT07165847 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
Advanced Solid Cancer
Minghui Pharmaceutical (Hangzhou) Ltd · started 2025-07-17
📍 Guangzhou
NCT06985355 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Shandong New Time Pharmaceutical Co., LTD · started 2025-07-02
📍 Tianjin
NCT07312188 on ClinicalTrials.gov ↗
Starting soon Phase 1
JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma
B-Cell Non-Hodgkin Lymphoma, Large B Cell Diffuse Lymphoma, Follicular Lymphoma, Marginal Zone B Cell Lymphoma
Peking University Cancer Hospital & Institute · started 2025-07-01
📍 Beijing
NCT07024147 on ClinicalTrials.gov ↗
Recruiting
Study on the Trans-Carotid Artery Occlusion Shunt System
Revascularization, Carotid Artery Stenosis, Carotid Artery Diseases
Shenzhen Wecan Medical Technology Co.,Ltd · started 2025-06-30
📍 Beijing
NCT06924593 on ClinicalTrials.gov ↗
Recruiting
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Gastritis, Gastric Dysplasia, Gastric Ulcer, Gastric Cancer
Nanfang Hospital, Southern Medical University · started 2025-06-24
📍 Guangzhou
NCT07032961 on ClinicalTrials.gov ↗
Recruiting
AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)
Hepatecellular Carcinoma, Hepatectomy
Tongji Hospital · started 2025-06-10
📍 Wuhan
NCT07062380 on ClinicalTrials.gov ↗
Active
Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques
Acute Coronary Syndrome
Yong He · started 2025-06-06
📍 Sichuan Chengdu
NCT06416813 on ClinicalTrials.gov ↗
Active Phase 2
Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University · started 2025-06-01
📍 Hangzhou
NCT07199855 on ClinicalTrials.gov ↗
Recruiting
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
Artificial Intelligence, Lung Nodule
Anhui Provincial Hospital · started 2025-06-01
📍 Hefei · Suzhou · Ningbo
NCT07098884 on ClinicalTrials.gov ↗
Recruiting
Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury
Acute Myocardial Infarction
The Second Hospital of Anhui Medical University · started 2025-05-29
📍 Hefei · Changsha
NCT06947135 on ClinicalTrials.gov ↗
Recruiting Phase 3
Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer
Ovarian Cancer
Tongji Hospital · started 2025-05-27
📍 Wuhan
NCT06954584 on ClinicalTrials.gov ↗
Recruiting
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
Bipolar Depression
First Affiliated Hospital of Zhejiang University · started 2025-05-20
📍 Hangzhou
NCT07021508 on ClinicalTrials.gov ↗
By invitation
A Study of GD007 (Human iPSC-Exosome Liquid Dressing) for Safety and Dose-Finding in Moderate-Severe Intrauterine Adhesions
Moderate-Severe Intrauterine Adhesions
The First Affiliated Hospital with Nanjing Medical University · started 2025-05-04
📍 Nanjing
NCT07101484 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · started 2025-04-24
📍 Beijing · Guangzhou
NCT06929624 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of BGM0504 in Participants With Obesity
Obesity
BrightGene Bio-Medical Technology Co., Ltd. · started 2025-04-03
📍 Beijing
NCT06911203 on ClinicalTrials.gov ↗
Starting soon Phase 2
Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases
Leptomeningeal Metastases
Zhejiang Cancer Hospital · started 2025-04
📍 Hangzhou
NCT06861218 on ClinicalTrials.gov ↗
Recruiting
Effects of Barley Green on Visceral Fat Area in the Human Body and Investigation Into the Associated Mechanism of Intestinal Microbiota
People With High Body Fat Percentage, People With High Visceral Fat Area
Peking University People's Hospital · started 2025-03-19
📍 Beijing
NCT06886048 on ClinicalTrials.gov ↗
Recruiting
Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
Low Apgar Scores
Peking University Third Hospital · started 2025-03-11
📍 Beijing
NCT06961123 on ClinicalTrials.gov ↗
Recruiting
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Guangzhou Concord Cancer Center · started 2025-03-10
📍 Guangzhou · Guanzhou
NCT07412314 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
Acute Lymphoblastic Leukemia, Pediatric
The First Affiliated Hospital of Zhengzhou University · started 2025-03-01
📍 Zhengzhou
NCT06564493 on ClinicalTrials.gov ↗
Recruiting
Second-line Immunotherapy for ES-SCLC
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Tianjin Medical University Cancer Institute and Hospital · started 2025-02-28
📍 Tianjin
NCT06853678 on ClinicalTrials.gov ↗
Active Phase 3
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. · started 2025-02-13
📍 Tianjin
NCT06778967 on ClinicalTrials.gov ↗
Recruiting
Defocus-Enhanced vs. Single Vision Spectacles in Myopia Control Visual Function Training
Myopia
Beijing Visionly Plus Eye Hospital · started 2025-02-08
📍 Beijing
NCT06821074 on ClinicalTrials.gov ↗
Recruiting
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
Migraine Disorders, Brain, rTMS Stimulation
Ruijin Hospital · started 2025-02-06
📍 Shanghai
NCT06796725 on ClinicalTrials.gov ↗
Recruiting
Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury
Traumatic Brain Injury, Cognitive Dysfunction
Beijing Tiantan Hospital · started 2025-02-01
📍 Beijing
NCT07413562 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
CML,Blast Phase
Institute of Hematology & Blood Diseases Hospital, China · started 2025-01-26
📍 Tianjin
NCT06757855 on ClinicalTrials.gov ↗
Recruiting
Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
Ovarian Cancer (OvCa)
Xiangya Hospital of Central South University · started 2025-01-01
📍 Changsha
NCT06760923 on ClinicalTrials.gov ↗
Starting soon Phase 1
Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma
High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd. · started 2025-01-01
📍 Wuhan
NCT06737146 on ClinicalTrials.gov ↗
Recruiting Phase 4
Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients
Depressed Insomniac Co-morbid Patients
Tongji University · started 2025-01-01
📍 Shanghai
NCT06740188 on ClinicalTrials.gov ↗
Recruiting
Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease
Inflammatory Bowel Disease
Wecare Probiotics Co., Ltd. · started 2025-01-01
📍 Suqian
NCT06781827 on ClinicalTrials.gov ↗
Active
A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
Renal Cell Carcinoma (RCC)
Second Xiangya Hospital of Central South University · started 2025-01-01
📍 Changsha
NCT07060248 on ClinicalTrials.gov ↗
Recruiting
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
DLBCL
Ruijin Hospital · started 2025-01-01
📍 Shanghai
NCT06779435 on ClinicalTrials.gov ↗
Recruiting Phase 1
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Advanced Solid Tumor
BeOne Medicines · started 2024-12-09
📍 Bengbu · Hefei · Beijing · Fuzhou · Xiamen · Nanning
NCT06625593 on ClinicalTrials.gov ↗
Starting soon
Effects of rTMS on the Anxiety State of Older Patients With GAD
Generalized Anxiety Disorder
Yi Yang · started 2024-12-01
📍 Changchun
NCT05883774 on ClinicalTrials.gov ↗
Starting soon
Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases
First Affiliated Hospital of Harbin Medical University · started 2024-12
📍 Harbin
NCT06680076 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)
Lichen Simplex Chronicus
Sanofi · started 2024-11-25
📍 Chongqing · Guangzhou · Wuhan
NCT06687980 on ClinicalTrials.gov ↗
Recruiting Phase 2
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
NSCLC, Neoadjuvant Immunotherapy, Low Dose Radiotherapy, Sintilimab
Anhui Provincial Cancer Hospital · started 2024-11-20
📍 Hefei
NCT06714708 on ClinicalTrials.gov ↗
Recruiting Phase 2
Arsenous Acid for Refractory Triple-Negative Breast Cancer
Breast Cancer
Sun Yat-sen University · started 2024-10-23
📍 Guangzhou
NCT06678048 on ClinicalTrials.gov ↗
Starting soon
Multi-parametric Functional MRI in Patients of Chronic Kidney Disease
Chronic Kidney Disease(CKD), MRI
The First Affiliated Hospital with Nanjing Medical University · started 2024-10-01
📍 Nanjing
NCT06639685 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc. · started 2024-09-27
NCT06492616 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
Safety, Tolerability, GenSci098, Thyroid Eye Disease (TED)
Changchun GeneScience Pharmaceutical Co., Ltd. · started 2024-09-24
📍 Shanghai
NCT06569758 on ClinicalTrials.gov ↗
Recruiting
The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
Gastric Cancer, Gastroesophageal Junction Cancer
Fudan University · started 2024-09-05
📍 Shanghai
NCT06786169 on ClinicalTrials.gov ↗
Recruiting
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Endometrial Cancer, Endometrioid Carcinoma, Mismatch Repair Deficiency
Peking University People's Hospital · started 2024-09-02
📍 Beijing
NCT06549855 on ClinicalTrials.gov ↗
Starting soon
OXiris for Abdominal SEptic Shock (OASES Study)
Septic Shock, Abdominal Sepsis, Multi Organ Failure, Blood Purification
RenJi Hospital · started 2024-08-15
📍 Shanghai
NCT06504316 on ClinicalTrials.gov ↗
Recruiting Phase 2
Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.
Non-Small-Cell Lung Cancer
Avistone Biotechnology Co., Ltd. · started 2024-08-07
📍 Guangzhou
NCT06574347 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects
Healthy
RemeGen Co., Ltd. · started 2024-08-05
📍 Guiyang · Chengdu · Tianjin
NCT06549959 on ClinicalTrials.gov ↗
Active Phase 3
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Acute Ischemic Stroke, Large Infarct Core
Wan-Jin Chen · started 2024-08-01
📍 Hefei · Taihe Chengguanzhen · Wuhu · Anxi · Fuqing · Fuzhou
NCT06360458 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I
Mucopolysaccharidosis Type I
West China Hospital · started 2024-07-22
📍 Chengdu
NCT06519552 on ClinicalTrials.gov ↗
Active
FIH of PFBalloon for PVI
Paroxysmal Atrial Fibrillation
The Third People's Hospital of Chengdu · started 2024-07-10
📍 Chengdu
NCT07320976 on ClinicalTrials.gov ↗
Recruiting
XOR Levels in OSA Patients (XOR-OSA)
Obstructive Sleep Apnea
Nanjing Medical University · started 2024-07-01
📍 Nanjing
NCT06554496 on ClinicalTrials.gov ↗
Active
Health Behavior Nudge Strategies for Chronic Disease Patients: the Study of Hypertension and Type 2 Diabetes
Economics, Behavioral, Hypertension, Type 2 Diabetes Mellitus (T2DM), Self-management Behavior
Lin Han · started 2024-07-01
📍 Lanzhou
NCT06588127 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
Lupus Nephritis, IgG4-related Disease
Tongji Hospital · started 2024-07
📍 Wuhan
NCT06497361 on ClinicalTrials.gov ↗
Recruiting Phase 2
Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China · started 2024-06-25
📍 Tianjin
NCT06608342 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd. · started 2024-06-04
📍 Fuzhou · Guangzhou · Nanning · Haikou · Shijiazhuang · Harbin
NCT06459973 on ClinicalTrials.gov ↗
Recruiting Phase 2
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
Esophagogastric Junction Adenocarcinoma
Ruijin Hospital · started 2024-05-22
📍 Shanghai
NCT06482788 on ClinicalTrials.gov ↗
Active Phase 3
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)
HR+HER2- Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. · started 2024-04-24
📍 Beijing
NCT06343948 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
Polycythemia Vera
Mabwell (Shanghai) Bioscience Co., Ltd. · started 2024-03-21
📍 Zhengzhou · Wuhan · Nanchang · Tianjin · Hangzhou
NCT06752746 on ClinicalTrials.gov ↗
Recruiting
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder, Paranoid Psychosis
Shanghai Mental Health Center · started 2024-03-12
📍 Shanghai
NCT06904079 on ClinicalTrials.gov ↗
Recruiting
Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol
Degenerative Spondylolisthesis, Lumbar Spinal Stenosis
Beijing Friendship Hospital · started 2024-03-01
📍 Beijing
NCT06394089 on ClinicalTrials.gov ↗
Active Phase 2
HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Tongji Hospital · started 2023-12-30
📍 Wuhan
NCT06187961 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin Lymphoma (B-NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2023-12-27
📍 Wuhan
NCT06693973 on ClinicalTrials.gov ↗
Recruiting Phase 4
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China · started 2023-11-22
📍 Tianjin
NCT05888870 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Malignant Neoplasm of Liver
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · started 2023-09-30
📍 Wuhan
NCT06383520 on ClinicalTrials.gov ↗
Recruiting EARLY_Phase 1
CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)
Neovascular Age-related Macular Degeneration(nAMD)
HuidaGene Therapeutics Co., Ltd. · started 2023-09-04
📍 Shanghai · Tianjin
NCT06031727 on ClinicalTrials.gov ↗
Active Phase 1
Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
Healthy
Zhejiang Echon Biopharm Limited · started 2023-08-24
📍 Changsha
NCT06423261 on ClinicalTrials.gov ↗
Active Phase 2
FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms
Safety, Antitumor Activity, PK Profile
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · started 2023-08-16
📍 Wuhan
NCT06858618 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Advanced Solid Tumors
AskGene Pharma, Inc. · started 2023-08-02
📍 Beijing · Shanghai
NCT05867420 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University · started 2023-08-01
📍 Guangzhou
NCT05985798 on ClinicalTrials.gov ↗
Active Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B
Chronic Hepatitis B Virus
Grand Theravac Life Sciences (Nanjing) Co., Ltd. · started 2023-06-01
📍 Beijing
NCT07190742 on ClinicalTrials.gov ↗
Recruiting
Consistency of Carotid Doppler Blood Flow and Thermodilution Technique
Cardiac Surgery
Shanghai Zhongshan Hospital · started 2023-05-31
📍 Shanghai
NCT05944146 on ClinicalTrials.gov ↗
Recruiting
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis, Coronary Artery Disease Progression
Peking Union Medical College Hospital · started 2023-05-17
📍 Beijing
NCT05860400 on ClinicalTrials.gov ↗
Recruiting Phase 4
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
ANCA-associated Vasculitis, Maintenance Therapy
Chinese SLE Treatment And Research Group · started 2023-03-09
📍 Beijing
NCT05965284 on ClinicalTrials.gov ↗
Recruiting
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
Metastatic Breast Cancer
Sun Yat-sen University · started 2022-10-10
📍 Fuzhou · Dongguan · Foshan · Guangzhou · Shantou · Shaoguan
NCT06551220 on ClinicalTrials.gov ↗
Active
Healthy Weight Management Project for Overweight and Obesity Children
Obesity
Ningbo No. 1 Hospital · started 2022-09-01
📍 Ningbo
NCT05482191 on ClinicalTrials.gov ↗
Recruiting Phase 2
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · started 2022-05-20
📍 Guangzhou
NCT05351788 on ClinicalTrials.gov ↗
Recruiting Phase 2
Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma
Multiple Myeloma, Lymphoma
Institute of Hematology & Blood Diseases Hospital, China · started 2022-04-26
📍 Hefei · Beijing · Zhengzhou · Jinan · Tianjin
NCT05294055 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer
Beijing Friendship Hospital · started 2022-04-01
📍 Beijing
NCT05245474 on ClinicalTrials.gov ↗
Recruiting
PD-L1 Targeting Molecular Imaging of Solid Tumors
Gastrointestinal Tumors
Peking University Cancer Hospital & Institute · started 2021-07-20
📍 Beijing
NCT04629326 on ClinicalTrials.gov ↗
Active Phase 3
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)
Metastatic Castration-resistant Prostate Cancer
AstraZeneca · started 2021-06-24
📍 Beijing · Chongqing · Guangzhou · Guizhou · Henan · Hubei
NCT05171816 on ClinicalTrials.gov ↗
Recruiting Phase 4
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital · started 2021-03-25
📍 Tianjin
NCT05035147 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Hematological Malignancies
Janssen Research & Development, LLC · started 2021-02-01
📍 Beijing · Guangzhou · Hangzhou · Suzhou · Tianjin · Xi'an
NCT04634552 on ClinicalTrials.gov ↗
Starting soon EARLY_Phase 1
IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
Zhejiang University · started 2020-11-15
📍 Hangzhou
NCT04599543 on ClinicalTrials.gov ↗
Recruiting
Real World Study of Classic Infectious Disease
Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar
Huashan Hospital · started 2020-05-13
📍 Shanghai
NCT04020536 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
Breast Cancer
Hebei Medical University Fourth Hospital · started 2020-03-01
📍 Shijiazhuang
NCT04290793 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients
Non Hodgkin Lymphoma
Xynomic Pharmaceuticals, Inc. · started 2020-01-08
📍 Beijing · Hangzhou · Tianjin · Xuzhou
NCT04024696 on ClinicalTrials.gov ↗
Recruiting Phase 1
APG-2449 in Patients With Advanced Solid Tumors
Advanced Solid Cancer, Non Small Cell Lung Cancer, Esophageal Cancer, Ovarian Cancer
Ascentage Pharma Group Inc. · started 2019-05-27
📍 Beijing · Fuzhou · Guangzhou · Zhengzhou · Wuhan · Changsha
NCT03917043 on ClinicalTrials.gov ↗
Recruiting
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
GIST of Stomach, Gastric Cancer, Surgery, Complication
Fujian Medical University · started 2018-10-11
📍 Fuzhou
NCT03716089 on ClinicalTrials.gov ↗
Active Phase 3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Newly Diagnosed
pharmaand GmbH · started 2018-05-14
NCT03522246 on ClinicalTrials.gov ↗
Recruiting
Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases（NCD）
Lifestyle Intervention, Non Communicable Diseases
Beijing Tsinghua Chang Gung Hospital · started 2018-01-01
📍 Beijing
NCT04567121 on ClinicalTrials.gov ↗
By invitation
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children · started 2012-08
📍 Tianjin
NCT02040714 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Beijing · 40 Shanghai · 31 Guangzhou · 22 Tianjin · 18 Wuhan · 12 Chengdu · 11 Hangzhou · 11 Nanjing · 11 Zhengzhou · 8 Changsha · 8 Fuzhou · 7 Hefei · 7

Browse by condition

Breast Cancer · 4 Safety · 2 Obesity · 2 Healthy · 2 Hepatocellular Carcinoma Non-rese… · 2 Myopia · 2 High-grade Glioma · 2 Gastric Cancer · 2 Advanced Solid Tumors · 2 Type 2 Diabetes Mellitus (T2DM) · 2 Pancreatic Cancer · 2 Coronary Artery Disease · 2 Multiple Myeloma · 2 Acute Ischemic Stroke · 2 Ovarian Cancer · 2 Esophageal Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china (Accessed: 13 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.